Billings, MT
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Montana Cancer Consortium, founded in 1995, is a small nonprofit in the Diseases & Disorders sector that reported $997K in total revenue in fiscal year 2024. Revenue fell 22% from the prior year — a significant decline worth monitoring. Expenses of $873K left a modest 13% surplus.
The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer treatment to Montana, Idaho, and Wyoming through National Cancer Institute (NCI) sponsored clinical research.
The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute...
The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research. In the year ending May 31, 2025, Montana Cancer Consortium participated in approximately 120 clinical trials and 374 patients were registered to clinical trials. The Montana Cancer Consortium membership consists of approximately 60 physician members located across 10 affiliate sites in Montana, Northern Wyoming and Idaho.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $997,428 | $1,281,172 | -0.2% |
| Expenses | $872,512 | $914,706 | 0.0% |
| Net Income | $124,916 | $366,466 | -0.7% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| John Schallenkamp MD | President | 4.00 |
Officer
Director
|
$0 | $0 | $0 |
| Jeffrey Allen MD | Vice-President | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Michelle Proper MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Christopher Goulet MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| James Hueftle MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Justin Thomas MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Amanda Dinsdale | Secretary/Treasurer | 40.00 |
Officer
Director
|
$94,806 | $17,954 | $112,760 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $997,428 | $872,512 | $847,887 | $124,916 |
| 2024 | $1,281,172 | $914,706 | $722,971 | $366,466 |
| 2023 | $606,614 | $857,790 | $361,432 | $-251,176 |
| 2022 | $897,407 | $859,211 | $606,905 | $38,196 |
| 2021 | $1,142,804 | $1,144,656 | $569,925 | $-1,852 |
| 2020 | $1,023,410 | $891,480 | $572,047 | $131,930 |
| 2019 | $962,008 | $978,290 | $439,752 | $-16,282 |
| 2018 | $868,519 | $905,128 | $455,732 | $-36,609 |
Compare Montana Cancer Consortium with other nonprofits in Montana and across the country.